The role of 3D printing in prostate cancer: From in vitro modeling to clinical applications

Prostate International · Published 2026-07-01 · DOI 10.1016/j.prnil.2026.07.004

Free full text

Authors (5)

Ayda Khatibi, Naimeh Mahheidari, Mozafar Khazaei, Dilan A. Jalal, Leila Rezakhani

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Khatibi, A., Mahheidari, N., Khazaei, M., et al. (2026). The role of 3D printing in prostate cancer: From in vitro modeling to clinical applications. Prostate International. https://doi.org/10.1016/j.prnil.2026.07.004

Related articles

• Testosterone dynamics and oncologic safety in biochemically recurrent prostate cancer: An analysis of intermittent androgen deprivation therapy schedules · Prostate International · 2026 · Same journal
• Holmium laser enucleation of the prostate versus transurethral resection of the prostate for benign prostatic hyperplasia: evidence from a Korean retrospective analysis using the Common Data Model · Prostate International · 2026 · Same journal
• Kicking the can down the road: stereotactic body radiotherapy’s role in prolonging systemic treatment efficacy in metastatic castration-resistant prostate cancer · Prostate International · 2026 · Same journal
• Clinicopathologic profile of Filipino men with low-risk prostate cancer and predictors of unfavorable pathology at radical prostatectomy · Prostate International · 2025 · Same journal
• How nations pursued prostate-specific antigen screening policy under restrictive guidelines: an implicit–explicit continuum · Prostate International · 2026 · Same journal
• Factors predicting the success of ejaculation preserving transurethral resection of the prostate: a prospective cohort study · Prostate International · 2026 · Same journal
• Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study · Prostate International · 2025 · Same journal
• Risk stratification for repeat prostate biopsy: PI-RADS 3 lesions and the differential role of PSA density · Prostate International · 2026 · Same journal
• Efficacy of tamsulosin 0.4 mg for the treatment in male with the international Prostate Symptom Score ≥ 20 compared with tamsulosin 0.2 mg · Prostate International · 2025 · Same journal
• Efficacy and safety of pentosan polysulfate therapy in patients with interstitial cystitis for relief of lower urinary tract symptoms: 15-year single center experience · Prostate International · 2025 · Same journal